Facebook
Twitter
LinkedIn
ForwardPharmacogenomics for Your Practice – Online
Role-based discounts are available. Click Register to view
 |  |  |
Pharmacogenomics (PGx), the study of how one’s genes may affect an individual’s response to medication, is an emerging field within patient care. This online course uses over 50 engaging videos from Mayo Clinic experts to teach you how pharmacogenomics testing can make an impact in your practice. Topics include fundamentals of pharmacogenomics, how to interpret test results yourself, and tips on how to implement pharmacogenomics into your practice. Learn through case studies and listen as expert panels debate controversial questions about the field. Includes over 16 hours of content that you can go through at your own pace at work, at home, and even on your mobile device!
 | Jennifer A. Bold, APRN, C.N.P., D.N.P. Family Medicine |
 | Jyothsna (Jo) Giri, M.D., M.B.A. |
 | Christopher B. Grilli, Pharm.D., R.Ph., M.B.A. |
 | Wayne (Nick) T. Nicholson, M.D., Pharm.D. Department of Anesthesiology |
Target Audience
This activity has been designed for pharmacists, physicians, nurse practitioners, physician assistants, nurses, students, and other members of the health care team.
Learning Objectives
Upon completion of this course, participants should be able to:
- Describe what to consider when implementing pharmacogenomics in clinical practice
- Apply pharmacogenomics test results to make recommendations for an individualized medication management plan
- Identify barriers and challenges of considering pharmacogenomics in patient care
Participation in this Mayo Clinic course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.
Additional Information
| Attachment | Size |
|---|---|
 Additional Information | 96.2 KB |
Pharmacogenomics Certificate Course
Pharmacogenomics (PGx) Principles and Concepts
Pharmacogenomics 101: An Introduction to Foundational Concepts
Christopher T. Grilli, Pharm.D., R.Ph., M.B.A.
Pharmacogenomics: Discovery and Translation
Liewei Wang, M.D., Ph.D.
Pharmacogenomics’ Emerging Role
Richard Weinshilboum, M.D.
Variability and Pharmacokinetic Principles
Wayne T. Nicholson, M.D., Pharm.D.
PGx from a Patient Perspective: GINA & Other Important Questions
Teresa M. Kruisselbrink, M.S., CGC, LCGC
Legal Implications of Pharmacogenomics Testing
Sharon C. Zehe, J.D.
Pharmacogenomics from the Patient Perspective: Panel Discussion
Darryl S. Chutka, M.D. (Moderator), Matthew J. Ferber, Ph.D., Karen M. Meagher, Ph.D. & Sharon C. Zehe, J.D.
Clinical Laboratory Testing in PGx: “the Lab” 101
Ann M. Moyer, M.D., Ph.D.
Clinical Laboratory Testing in PGx: Targeting Genotyping Technology
Ann M. Moyer, M.D., Ph.D.
Clinical Laboratory Testing in PGx: “Sequencing”
Ann M. Moyer, M.D., Ph.D.
Clinical Laboratory testing in PGx: “Reporting”
Ann M. Moyer, M.D., Ph.D.
Pharmacogenomics Application
Pharmacogenomics at the Clinic: Panel Discussion
Matthew E. Bernard, M.D., Jennifer A. Bold APRN, C.N.P., D.N.P., Darryl S. Chutka, M.D. (Moderator) & Paul Y. Takahashi, M.D.
Pharmacogenomics Testing: Role in Clinical Medicine
Denise M. Dupras, M.D., Ph.D.
Utilizing National Pharmacogenomics Guidelines and Other Resources
Jessica A. Wright, Pharm.D., R.Ph.
Pharmacogenomics: Case-Based Application
Pharmacogenomics of Analgesics
Wayne (Nick) T. Nicholson, M.D., Pharm.D.
Pharmacogenomics: Anesthesia
Timothy B. Curry, M.D., Ph.D.
Pharmacogenomics of Antidepressants
Adrijana Kekic, Pharm.D., R.Ph.
Case Review, SSRIs (Sertraline) and SNRIs
Adrijana Kekic, Pharm.D., R.Ph.
Psychiatric Pharmacogenomics: Panel Discussion
Darryl S. Chutka, M.D. (Moderator), Eric T. Matey, Pharm.D., R.Ph., Denise M. Dupras, M.D., Ph.D., Richard Weinshilboum, M.D.
Using Pharmacogenomics to Predict Drug Hypersensitivity
John D. Zeuli, Pharm.D., R.Ph.
Gout Management: Role of Pharmacogenomics
Denise M. Dupras, M.D., Ph.D.
HLA and Hypersensitivity: Carbamazepine
Jyothsna (Jo) Giri, M.D., M.B.A.
Pharmacogenomics in Cardiovascular Disease
Naveen L. Pereira, M.D.
Warfarin & Statin Pharmacogenomics Cases
Jan A. Anderson, Pharm.D., R.Ph.
Voriconazole
Christopher J. Arendt, Pharm.D., R.Ph.
Pharmacogenomics: Challenges with Liver & Hematopoietic Stem Cell Transplant
John Logan Black, M.D.
Pharmacogenomics for Transplant Patients: Immunosuppression and Beyond
Mira T. Keddis, M.D.
Polypharmacy and PGx: Multi-Drug, Herbal/Dietary Supplement Case Study
Michael J. Schuh, Pharm.D., R.Ph.
Case Study: Thiopourines/TPMT and NUDT15 in Clinical Practice
Edward V. Loftus, Jr. M.D.
PGx use in Patients with Gastroesophageal Reflux Disease
Imad Absah, M.D.
Dihydropyrimidine Dehydrogenase (DPD) Deficiency
Implications for 5-Fluorouracil (Capecitabine) Treatment
Robert B. Diasio, M.D.
Why is CYP2D6 Genotyping Ready for Primetime:
Association of CYP2D6 Genotype and Breast Cancer Outcome from Large Trials
Matthew P. Goetz, M.D.
Belinostate and UGT1A Polymorphism
N. Nora Bennani, M.D.
Case: Oncology
Caren L. Hughes, Pharm.D., R.Ph.
Pharmacogenomics in Oncology
Eric J. Yancey, Pharm.D., R.Ph.
Multi-Drug Phenoconversion Concept
Eric T. Matey, Pharm.D., R.Ph.
Pharmacogenomics at the Pharmacy: Panel Discussion
Christopher Grilli, Pharm.D., R.Ph.,M.B.A. (Moderator), Ashley D. Ebenhoh, Pharm.D., R.Ph.,
& Razan M. El Melik, Pharm.D., R.Ph.
Significant Pharmacogenomics Cases
Heather H. Randles, Pharm.D., R.Ph.
Case Review: From My Practice to Yours
Sheena K. Crosby, Pharm.D., R.Ph.
Pharmacogenomics Implementation
Sex, Drugs, and Genetic Variation
Ann M. Moyer, M.D., Ph.D.
10 Considerations for the Clinician Applying Pharmacogenomics to Practice
Wayne T. Nicholson, M.D., Pharm.D.
Education for the Multidisciplinary Team: Panel Discussion
Jyothsna (Jo) Giri, M.D., M.B.A., Christopher M. Kohler, M.A.N., R.N., N.E.-B.C., Tammy M. McAllister, M.A. (Moderator), & Lance J. Oyen, Pharm.D., R.Ph.
Developing an Individualized Medication Plan
Eric T. Matey, Pharm.D., R.Ph.
 | Imad Absah, M.D. |
| Christopher M. Kohler, M.A.N., R.N., N.E.-B.C. Nursing Administration | |
 | Jan A. Anderson, Pharm.D., R.Ph. |
| Teresa M. Kruisselbrink, M.S., CGC, LCGC Center for Individualized Medicine | |
 | Christopher J. Arendt, Pharm.D., R.Ph. |
| Konstantinos N. Lazaridis, M.D. Gastroenterology | |
 | N. Nora Bennani, M.D. Hematology |
| Edward V. Loftus, Jr. M.D. Gastroenterology | |
 | Matthew E. Bernard, M.D. Family Medicine |
| Eric T. Matey, Pharm.D., R.Ph. | |
 | John Logan Black, M.D. Genomics |
| Tammy M. McAllister, M.A. Center for Individualized Medicine | |
 | Jennifer A. Bold, APRN, C.N.P., D.N.P. Family Medicine |
| Karen M. Meagher, Ph.D. Biomedical Ethics | |
 | Sheena K. Crosby, Pharm.D., R.Ph. Pharmacy |
| Ann M. Moyer, M.D., Ph.D. Laboratory Medicine & Pathology | |
 | Timothy B. Curry, M.D., Ph.D. Anesthesia |
| Wayne (Nick) T. Nicholson, M.D., Pharm.D. Clinical Pharmacology | |
 | Robert B. Diasio, M.D. Pharmacology - Cancer Center |
| Lance J. Oyen, Pharm.D., R.Ph. Pharmacy | |
 | Denise M. Dupras, M.D., Ph.D. Community Internal Medicine |
| Naveen L. Pereira, M.D. Cardiovascular Medicine | |
 | Ashley D. Ebenhoh, Pharm.D., R.Ph. Pharmacy |
| Heather H. Randles, Pharm.D., R.Ph. Pharmacy | |
 | Razan M. El Melik, Pharm.D., R.Ph. Pharmacy |
| Michael J. Schuh, Pharm.D., R.Ph. Pharmacy | |
 | Matthew J. Ferber, Ph.D. Center for Individualized Medicine |
| Paul Y. Takahashi, M.D. Community Internal Medicine | |
 | Jyothsna (Jo) Giri, M.D. Center for Individualized Medicine |
| Liewei Wang, M.D., Ph.D. Schulze Center for Novel Therapeutics | |
 | Matthew P. Goetz, M.D. Medical Oncology |
| Richard Weinshilboum, M.D. Schulze Center for Novel Therapeutics | |
 | Christopher B. Grilli, Pharm.D., R.Ph., M.B.A. Pharmacy |
| Jessica A. Wright, Pharm.D., R.Ph. | |
 | Caren L. Hughes, Pharm.D., R.Ph. Pharmacy |
| Eric J. Yancey, Pharm.D., R.Ph. Pharmacy | |
 | Mira T. Keddis, M.D. Nephrology |
| Sharon C. Zehe, J.D. Legal Department | |
 | Adrijana Kekic, Pharm.D., R.Ph. Pharmacy |
| John D. Zeuli, Pharm.D., R.Ph. Medication Therapy Management |
Accreditation Statement:
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 16.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACPE
Mayo Clinic College of Medicine and Science designates this educational activity for a maximum of 16.00 ACPE Knowledge-based contact hours. Participants should claim only the credit commensurate with the extent of their participation in the activity.
ANCC
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 16.00 ANCC nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 16.00 ACPE
- 16.00 AMA PRA Category 1 Credit™
- 16.00 ANCC
- 16.00 Attendance
Accreditation Period
Price
Full Fee: M.D., D.O., Ph.D. | $1099 |
Reduced Fee: NP, PA, Pharmacist | $799 |
Other Allied Health Professional | $599 |
Cancellation and Refund Policy:
Request for cancellations must be submitted in writing to cme@mayo.edu.
Any use of this site constitutes your agreement to the Terms and Conditions of Online Registration.